Cost-effectiveness analysis of oxaliplatin/5-FU/LV in adjuvant treatment of stage III colon cancer in the US
2005 Journal of Clinical Oncology, 2005 ASCO Annual Meeting Proceedings
Aballea, S. | Chancellor, J. | Raikou, M. | Drummond, M. | Weinstein, M. | Jourdan, S. | Carita, P. | Bridgewater, J. |
Volume: 23,
Issue: 16S (June 1 Supplement),
Pages: 3532,
colon cancer, cost-effectiveness analysis,
